Literature DB >> 68263

Unusual prevalence of antibodies to Epstein-Barr virus early antigen in ataxia telangiectasia.

J Joncas, N Lapointe, F Gervais, M Leyritz, A Wills.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 68263     DOI: 10.1016/s0140-6736(77)92425-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2012-02-12

2.  Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia.

Authors:  A I Berkel; W Henle; G Henle; G Klein; F Ersoy; O Sanal
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

3.  Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis.

Authors:  P B Ferrell; C T Aitcheson; G R Pearson; E M Tan
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

Review 4.  Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients.

Authors:  G Masucci; I Berkel; M G Masucci; I Ernberg; R Szigeti; F Ersoy; O Sanal; O Yegin; G Henle; W Henle
Journal:  J Clin Immunol       Date:  1984-09       Impact factor: 8.317

5.  Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.

Authors:  J H Joncas; A Wills; E Reece; Z Fox
Journal:  Can Med Assoc J       Date:  1981-10-15       Impact factor: 8.262

6.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.